ABOUT US
NEWS & INSIGHTS

About Us

About Us

Quartz Bio Logo

Alessandro Di Cara, PhD
Senior Director

Lead Biological Systems
+41 (0)22.552.0478

  

Leading expert in flow cytometry and systems biology. Senior bioinformatics scientist with a focus on exploratory immunological biomarker data analyses and long-standing experience in the pharmaceutical industry. Holds a doctorate in cell biology from Friedrich Miescher Institute in Basel, Switzerland.

Globe Icon

Chad Clark
President

240.654.0730

  

Recognized industry leader focused on combining cutting-edge technology, strategic program design, and operational excellence to help life sciences companies effectively address the increasing evidence demands and need to accelerate research initiatives. Previous experience spans the execution of phase I-IV clinical trials, specialty lab services, biospecimen logistics and banking, risk management, and patient support initiatives.

Globe Icon

Imran Fanaswala
Director of Technology

+41 (0)22.552.0470

  

Established industry leader focused on harnessing sane statistics for machine learning, bioinformatics, and R&D. Experienced in the entire pipeline from prototyping to deployment, always keeping overarching business and regulatory practices in mind. Passionate about succinct scientific communication to all stakeholders, leading to actionable insights.

Jared Kohler, PhD
Senior Vice President

Translational Informatics and Biometrics
240.306.4109

  

Extensive industry expertise across the pharmaceutical and biotech space—translational research, data management, and statistical support—with a focus in precision medicine-guided efforts in drug and diagnostic development. Subject matter expert in genomics. Pioneered approaches in biomarker data management and has led Biometrics operations on over 70 clinical studies.

Jérôme Wojcik, PhD
Senior Vice President

Translational Informatics and Biometrics
+41 (0)22.552.0472

  

Noted bioinformatics expert across pharmaceutical and biotech industries. Focused on exploratory biomarker data analyses for the implementation of precision medicine. Specialized knowledge of operational management and biomarker data sciences. Former director of global bioinformatics at Merck Biopharma.

Karl Forner, MSc
Senior Director

Lead Informatics
+41 (0)22.552.0477

  

Respected expert in mathematics and fundamental and theoretical computer science. Strong focus on genetics. Developer of innovative bioinformatics algorithms for SNP analyses and genome-wide association studies. Avid proponent of and proactive contributor to the open source community.

Marc Lamarine, PhD
Senior Director

Lead Operations
+41 (0)22.552.0474

  

Leading expert in the analysis of large-scale, high-throughput genomics and genetics data. Statistical programmer combining computational and experimental methods in various therapeutic areas, eg, oncology and autoimmune disease.

Globe Icon

Matthew Hall, PhD
Senior Director

Business Development
+41 (0)76.241.0325

  

Leading strategy expert in end-to-end bioinformatics and artificial intelligence solutions for biomarker-guided drug development, maximizing the value and utility of biomarker data in clinical trials, CDx, and diagnostics. Former CEO of SimplicityBio, holds a doctorate in molecular and cellular biology from the University of Lausanne.

Globe Icon

Pedro Faustino, MBA
Senior Director

Customer Solutions
+41 (0)22.552.0470

  

Deep expertise in healthcare technology with a focus on using artificial intelligence to help biopharma and diagnostic companies solve the question, “Which therapy, when, and for which patient?” Extensive industry knowledge across the pharmaceutical and biotech space—translational informatics, biomarker R&D. Holds an MBA and is passionate about exploring interfaces between people and tech, effective communication, hiking, and sailing.

Scott Marshall, PhD
Managing Director

Translational Informatics and Diagnostic Sciences
240.306.4110

  

Extensive industry expertise across the pharmaceutical and biotech space—Dx regulatory submissions, translational informatics, biomarker R&D—with a focus in precision medicine-guided efforts as well as strategy development and medical device/diagnostic development. Globally responsible for translational informatics R&D efforts. Has led the development of novel methodologies for patient stratification and biomarker guided clinical trial design.

Tobias Guennel, PhD
Vice President

Chief Architect, QuartzBio
240.306.4119

  

Extensive industry expertise across the pharmaceutical and biotech space—regulatory submissions, translational informatics, biomarker R&D—with a focus in precision medicine-guided efforts as well as strategy development and medical device/diagnostic development. Led numerous analytical R&D efforts and developed novel methodologies to harmonize and analyze data from high-throughput assays, translating it to value at the patient level.

News & Insights

More information and news about QuartzBio and Precision for Medicine

QuartzBio in Clinical Omics

Press release: Acquisition of SimplicityBio Enhances QuartzBio

Precision Translational Solutions

Precision for Medicine supports life sciences companies in the use of biomarkers essential to targeting patients more precisely and effectively. Precision applies novel biomarker approaches to clinical research that take advantage of the latest advancements in science and technology, focusing predominantly on genomics, immune-response assays, global specimen logistics, biomarker analytics, companion diagnostics, and clinical trial execution.